← Eichor
Condition: Polyarticular Juvenile Idiopathic Arthritis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Polyarticular Juvenile Idiopathic Arthritis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
Phase 3 · 79 location(s) · Eli Lilly and Company · NCT03773965Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib for the Treatment of Polyarticular-course Juvenile Id
Phase 3 · 14 location(s) · Alfasigma S.p.A. · NCT07554495Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT07184450Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis
Phase 3 · 6 location(s) · Duke University · NCT06654882Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis
Phase N/A · 1 location(s) · Pfizer · NCT05754710
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.